Introduction
Stimuli that activate innate immune cells such as dendritic cells (DCs) 1 that switch on production of proinflammatory mediators such as IL-12 and tumor necrosis factor (TNF)α, costimulatory molecules from B7 family, and adhesion molecules, for example, endothelial cell-leukocyte adhesion molecule (ELAM-1; E-selectin). Given the importance of IL-12 in cell-mediated immunity (4), the indispensability of costimulatory molecules for full activation of lymphocytes (5) , and the role of adhesion molecules in recruiting leucocytes (6) and forming the proper immunological synapses between interacting cells (7) , it becomes clear why TLRs have the central position in both innate and adaptive anti-infectiuos responses.
Alternatively it has been suggested that DCs act as sentinels of 'endogenous' ligands released from cells undergoing unprogrammed necrotic death as opposed to 'silent' programmed cell death, i.e., apoptosis (8;9) . According to this view not the 'foreign-ness' is sensed but the danger, thus the name 'danger hypothesis' (10 
Experimental Procedures

Plasmids and Reagents
A Flag epitope-tagged C-terminus of murine MyD88 (dnMyD88) was described (19) . The expression vectors for C-terminus of human TRAF6 (dnTRAF6), human flag-tagged TLR2,
TLR4 and E-selectin (ELAM-1) promoter luciferase construct were gifts from Tularik, Inc.
(South San Francisco, CA), murine TLR9 in pcDNA3 was a gift from S. Bauer (Technical University of Munich, Munich, Germany), the human MD-2 expression vector was kindly provided by K. Miyake (Saga Medical School, Nabeshima, Japan). The luciferase reporter driven by a synthetic enhancer harboring 6 NF-κB binding consensus sites was a gift from P.
Baeuerle (Munich, Germany). The IL-12p40 promoter (-703 to +53) luciferase construct was a gift from K.M. Murphy (Washington University, St. Louis, MO).
Recombinant human HSP70 was purchased from StressGen Biotechnologies (Victoria, Canada). To control contamination with LPS HSP70 preparations were boiled for 30-60 min where indicated. Phosphothioate stabilized CpG oligonucleotide 1668 (TCC-ATG-ACG-TTC-CTG-ATG-CT) was purchased from TIB MOLBIOL (Berlin, Germany). LPS from Escherichia coli 055:B5 and PMA were from Sigma-Aldrich (Munich, Germany).
Cell Culture, Transfection, and Luciferase Assays
The murine macrophage cell line RAW264.7 was grown in VLE-RPMI medium (Biochrom KG, Berlin, Germany) supplemented with 10% fetal calf serum (FCS), 100 IU/ml penicillin G, and 100 IU/ml streptomycin sulfate (all from Biochrom KG). 5-10⋅10 6 RAW264. 
Mice, Generation of BMDDC, and Determination of Cytokines
MyD88-deficient mice were a kind gift from S. Akira (Osaka University, Osaka, Japan) (20) .
Gene targeted mice deficient for TLR2 (TLR2 -/-) were granted by Tularik Inc. Bone marrow derived dendritic cells (BMDC) were prepared as described (23) . For stimulation, nonadherent BMDC at days 6-7 were washed, plated at 3.8-7.5⋅10 5 /ml and after a 2 hr rest cells as an uptake receptor for HSP70 (24) . Since high amounts of α 2 -macroglobulin are present in FCS one could presume an inhibitory effect of serum on HSP70 interaction with macrophages.
To probe for that possibility serum-free stimulation with HSP70 was performed. As shown in shown). To rule out unspecific or toxic effects of overexpressed dominant-negative constructs stimulation of cells by hypoosmotic stress was used as specificity control (Fig.2) .
Visualization of MyD88 recruitment by HSP70
Since a dominant-negative version of MyD88 suppressed HSP70 induced signaling we next attempted to visualize HSP70 driven recruitment of MyD88 to subcellular sites where signaling is initiated. RAW264.7 macrophage clones stably expressing MyD88 fused to Enhanced green fluorescent protein (EGFP) were selected and analyzed by confocal laser scanning microscopy upon activation with HSP70 (5 µg/ml, 2 hr stimulation). As shown in Fig.3A MyD88-EGFP was homogenously distributed within the cytoplasm in nonstimulated cells. Upon stimulation with HSP70 MyD88-EGFP became recruited to irregularly distributed endosome-like vesicular structures and partially to the cell membrane (Fig.3B) . Heat denatured HSP70 failed to cause any changes of MyD88 distribution within the cells (Fig.3C ). These data confirmed the involvement of the Toll/IL-1 receptor signal pathway and suggested that HSP70 may initiate signaling upon endocytosis as has been described for HSP60 (19) .
Verification of MyD88 involvement in cell activation by HSP70
Next we used cells from MyD88-deficient mice to verify the central role of MyD88 in cell activation by HSP70. HSP70 has been shown to stimulate murine antigen presenting cells to produce IL-12p40 and TNFα (14) . We therefore analyzed the ability of HSP70 to trigger production of aforementioned cytokines in murine DCs derived from bone marrow (BMDC) of MyD88-defficient mice and of respective control mice. HSP70 dose-dependently caused BMDC from control mice to initiate IL-12p40 (Fig.4A) and TNFα (Fig.4B) production, yet responsiveness of MyD88-deficient BMDC was ablated. Heat inactivated HSP70 showed no stimulatory activity for DCs. To control that wild-type and knock-out DCs were responsive, the Stimulation under serum-free conditions was performed synchronously, in order to test for potential enhancement of the stimulatory capacity of HSP70. Serum deprivation affected cytokine production at higher HSP70 concentrations (Fig.4) . This result might be explained by a negative impact on cytokine production of the stress imposed by serum deprivation. Indeed, stimulation with PMA under FCS-free conditions resulted in reduced TNFα production, supporting this explanation.
Overall these results confirmed that signaling for HSP70 driven cytokine production occurs via the Toll/IL-1 receptor signal pathway.
HSP70 signals via TLR2 and TLR4
The essential role of MyD88 and TRAF6 in HSP70 triggered cell activation suggested an involvement of Toll-like receptors. To analyze this possibility we first utilized genetic complementation with TLRs of the HSP70-unresponsive human embryonic kidney fibroblast cell line 293T. Cells were transiently transfected with a luciferase reporter driven by a synthetic enhancer harboring 6 NF-κB binding consensus sites. Upon cotransfection with TLR2 the cells gained responsiveness to HSP70 (and LPS (27)) but not to heat inactivated HSP70 (Fig.5A) .
Interestingly, cotransfection of TLR4 alone was ineffective, yet cotransfection of TLR4 plus MD-2, a coreceptor of TLR4 in case of LPS signaling (28), resulted unequivocally in responsiveness (Fig.5A ). The grade of HSP70 induced NF-κB activity was comparable to that caused by LPS, implying that stimulatory potential of endogenous ligand HSP70 is as high as that of the potent microbial stimulus LPS. Gain of function was TLR-specific, since TLR9 conferred responsiveness to bacterial CpG-DNA, but not to HSP70 or LPS (Fig.5A) .
We also analyzed a potential role of serum components in this reductionist genetic complementation system. While the absence of FCS enhanced TLR2 mediated 'gain of function' dose-dependently, TLR4 plus MD-2 mediated HSP70 responsiveness was not influenced by serum and the dose of the stimulus (Fig.5B) ) (Fig.6A,B) . To control for equal stimulatory conditions, IL12p40 production in response to CpG-DNA was measured, known to be TLR9 but not TLR2 or TLR4 dependent (Fig.6C) The α 2 -macroglobulin receptor (CD91) has been reported to function as an uptake receptor of HSP70 (24) . α 2 -Macroglobulin and/or other CD91 ligands present in serum may thus compete with HSP70 for CD91 and thus inhibit HSP70-APC interaction. Furthermore, we reported that the ability of HSP60 to activate DCs depends on endocytosis of HSP60 both being blocked by serum (19) . Here we describe recruitment of MyD88-EGFP to endosome-like vesicular structures after stimulation of macrophages with HSP70 implying that endocytosis of HSP70 may precede signaling (Fig.3A) . This conclusion bears a caveat, since TLR2 transfected fibroblasts showed a clear and dose dependent inhibitory effect of serum on the activity of HSP70 while TLR4 plus MD-2 transfected cells did not (Fig.5B) . It could well be that HSP70
activates TLR2 only upon endocytosis, while TLR4 is activated independently of internalization, as has been shown for CpG-DNA and LPS, respectively. 2 This question needs to be addressed by analyzing whether inhibition of endocytosis differentially affects HSP70 driven activation of TLR2 versus TLR4 plus MD-2 transfected cells.
Experimentally TLR2 conferred responsiveness of 293T cells to HSP70, yet TLR2-deficient BMDC responded to HSP70. Since TLR4-defective BMDC were completely unresponsive towards HSP70, we conclude that TLR2 does not autonomously function as a HSP70 receptor.
Whether a coreceptor is missing or a threshold concentration for HSP70-TLR2 signaling is much higher in BMDC needs to be analyzed.
As reported for HSP60 (19;30) we show here that HSP70 also acts as endogenous TLR ligand.
It follows that during evolution TLR family members have been selected as receptors for (Fig.3A) . 5µg/ml HSP70 (Fig.3B ) or same amount of heat inactivated HSP70 (Fig.3C) by guest on 
